No co-administration of Ketek tab. with Ketoconazole.

Published: 2007-02-06 06:57:00

Updated: 2007-02-06 06:57:00

The KFDA announced label changes for more than 100 products including Ketek (Telithromycin), which was instructed to add warnings of liver toxicity and no administration with Ketoconazole as a contra-indication.

The KFDA said on Feb. 1 that the total 98 products were instructed to change the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK